BEAT THE PRESS (NYT)

Thomas Friedman Again Demonstrates the Skills Shortage for NYT Pundits

April 24, 2013   ·   1 Comments

By Dean Baker: The NYT has difficulty finding pundits who can write knowledgeably about economics. Thomas Friedman made this point...

Nevermind: Headline of Correction for NYT Piece on Projected Cost of Dementia

By Dean Baker: The New York Times ran a front page piece warning readers that the cost of treating dementia is “soaring.” The piece tells readers of the ...

Warning: Wealth Comparisons by Age Group Through Time Are Bogus!

By Dean Baker: The NYT commits the common sin of making such comparisons in an otherwise useful piece on the economic plight of millennials. It tells us: “The average ...

Thomas Friedman Gets Lost South of the Border

By Dean Baker: In this century Mexico has had the slowest per capita GDP growth of any country in Latin America. It has made almost no progress in ...

Using Deceptive Numbers on Health Care in the NYT

By Dean Baker: It is really easy and apparently fun for some people to use scary numbers about health care costs. The trick is to take ...

To Educate a Cab Driver, Educate Thomas Friedman Campaign

By Dean Baker: Thomas Friedman is once again mass marketing misinformation on economics, something that he does all too frequently. Just about everything in the piece is ...

Currency Values Are Not Determined by the Market When Central Banks Buy Currencies

By Dean Baker: A NYT piece reported on concerns by the French government and others over the rising value of the euro. They were concerned that a higher ...

Fiscal Cliff Concerns Did Not Restrain Hiring

By Dean Baker: The NYT is still pushing the line that, “uncertainty over fiscal policy and the fragility of the economy still seem to be holding back employers.” ...

Thomas Friedman is Way Off Today

By Dean Baker: That’s a cheap shot derived from the information that the NYT gave us at the end of Thomas Friedman’s column: “Maureen Dowd is off ...

Pharmaceutical Companies Lead the Fight Against the Free Market

By Dean Baker: The NYT tells us that biotech firms want the government to prohibit pharmacists from giving patients generic substitutes for biological drugs. This is a great ...

Next Page »